| known also as: |
Angiogenic Inducer 61 (CYR61), Anti-Cysteine-rich |
| known also as: |
Angiogenic Inducer 61 (CYR61), Cysteine-rich |
| known also as: |
Angiogenic Inducer 61 (CYR61), Cysteine-rich |
| known also as: |
Angiogenic Inducer 61, Cysteine-rich |
| known also as: |
Angiogenic Inducer 61 (CYR61), Anti -Cysteine-rich |
| Other names: |
61, 61, 61, CCN family member 1, CCN family member 1, Cysteine-rich angiogenic inducer 61, IBP-10, IBP-10, IGF-binding protein 10, IGF-binding protein 10, IGFBP-10, IGFBP-10, Insulin-like growth factor-binding protein 10, OTTHUMP00000012303, Protein CYR61, Protein GIG1, angiogenic inducer, angiogenic inducer, anigogenic inducer, cysteine-rich, cysteine-rich, cysteine-rich heparin-binding protein 61, insulin-like growth factor-binding protein 10, isoform CRA_a, protein CYR61, cysteine-rich |
| Other gene names: |
CCN1, CCN1, CYR61, GIG1, GIG1, IGFBP10, IGFBP10, CYR61 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal |
| Immunoglobulin isotype: |
IgG |
| Clone: |
Polyclonal antibody |
| Host organism: |
Source: Human, Host: Rabbit |
| Species reactivity: |
Human |
| Specificity and cross-reactivity: |
96%, Species sequence homology: rat, 100% and mouse, Recognizes human CYR61 protein |
| Purification method: |
Affinity Purified by immunoaffinity chromatography |
| Form/Appearance: |
pH 7, 09% sodium azide, 5 0, Supplied as a liquid in Tris-citrate/phosphate buffer |
| Storage and shipping: |
Aliquots are stable for at least 12 months productone should be stored at -20 degrees Celsius, For long-term storage and to avoid repeated freezing and thawing, For maximum recovery of product, Further dilutions can be made in assay buffer, add sterile 40-50% glycerol, aliquot and For optimal long term storage, centrifuge the original vial after thawing and prior to removing the cap, productone should be kept at -20 degrees Celsius, Store at 4 degrees Celsius for short term storage |
| Tested for:: |
Western Blot (WB) |
| Description: |
Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions, Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, Properly used, To obtain more detailed information on productone, please, refer to the full product datasheet, the time needed for production is considerably shorter, they are inexpensive to manufacture and respectively to buy, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals_1 they should be stored frozen at - 24° |
| Gene target: |
Angiogenic Inducer 61 (CYR61), Cysteine-rich |
| Short name: |
Angiogenic Inducer 61 (CYR61) Antibody, Cysteine-rich |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
61) (Antibody to), Angiogenic Inducer 61 (cysteine-rich, angiogenic inducer, Cysteine-rich |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
61, CCN1 and GIG1 and IGFBP10, CYR61 and IDBG-100054 and ENSG00000142871 and 3491, CYR61 and IDBG-637282 and ENSBTAG00000009844 and 508941, Cyr61 and IDBG-198706 and ENSMUSG00000028195 and 16007, Extracellular, angiogenic inducer, extracellular matrix binding, spreading of cells and biological process this GO :0045597 and positive regulation of cell differentiation and biological process this GO :0045669 and positive regulation of osteoblast differentiation and biological process this GO :0045860 and positive regulation of protein kinase activity and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0050840 and extracellular matrix binding and molecular function this GO :0060413 and atrial septum morphogenesis and biological process this GO :0060591 and chondroblast differentiation and biological process this GO :0060710 and chorio-allantoic fusion and biological process this GO :0060716 and labyrinthine layer blood vessel development and biological process this GO :0061036 and positive regulation of cartilage development and biological process this GO :0070372 and regulation of ERK1 and ERK2 cascade and biological process this GO :0072593 and reactive oxygen species metabolic process and biological process this GO :2000304 and positive regulation of ceramide biosynthetic process and biological process, this GO :0001558 and regulation of cell growth and biological process this GO :0001649 and osteoblast differentiation and biological process this GO :0001934 and positive regulation of protein phosphorylation and biological process this GO :0002041 and intussusceptive angiogenesis and biological process this GO :0003181 and atrioventricular valve morphogenesis and biological process this GO :0003278 and apoptotic process involved in heart morphogenesis and biological process this GO :0003281 and ventricular septum development and biological process this GO :0005178 and integrin binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005520 and insulin-like growth factor binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0006935 and chemotaxis and biological process this GO :0007155 and cell adhesion and biological process this GO :0008201 and heparin binding and molecular function this GO :0008283 and cell proliferation and biological process this GO :0009653 and anatomical structure morphogenesis and biological process this GO :0010518 and positive regulation of phospholipase activity and biological process this GO :0010811 and positive regulation of cell-substrate adhesion and biological process this GO :0016337 and single organismal cell-cell adhesion and biological process this GO :0030198 and extracellular matrix organization and biological process this GO :0030335 and positive regulation of cell migration and biological process this GO :0030513 and positive regulation of BMP signaling pathway and biological process this GO :0033690 and positive regulation of osteoblast proliferation and biological process this GO :0043065 and positive regulation of apoptotic process and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043280 and positive regulation of cysteine-type endopeptidase activity involved in apoptotic process and biological process this GO :0044319 and wound healing, this GO :0005178 : integrin binding, this GO :0005178 : integrin binding and also this GO :0005515 : protein binding and also this GO :0005520 : insulin-like growth factor binding and also this GO :0008201 : heparin binding and also this GO :0050840 : extracellular matrix binding, this GO :0005515 : protein binding, this GO :0005520 : insulin-like growth factor binding, this GO :0008201 : heparin binding, this GO :0050840 : extracellular matrix binding, cysteine-rich |
| Identity: |
2654 |
| Gene: |
CYR61 |
More about : CYR61 |
| Long gene name: |
cysteine rich angiogenic inducer 61 |
| Synonyms gene: |
IGFBP10 |
| Synonyms gene name: |
61 , angiogenic inducer, cysteine-rich |
| Synonyms: |
GIG1 CCN1 |
| Locus: |
1p22, 3 |
| Discovery year: |
1998-03-02 |
| GenBank acession: |
AF031385 |
| Entrez gene record: |
3491 |
| Pubmed identfication: |
9135077 |
| RefSeq identity: |
NM_001554 |
| Classification: |
CYR61/CTGF/NOV matricellular proteins |
| Havana BLAST/BLAT: |
OTTHUMG00000010577 |